Literature DB >> 21645218

Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.

Jonel Trebicka1, Ildiko Racz, Sören V Siegmund, Erlind Cara, Michaela Granzow, Robert Schierwagen, Sabine Klein, Alexandra Wojtalla, Martin Hennenberg, Sebastian Huss, Hans-Peter Fischer, Jörg Heller, Andreas Zimmer, Tilman Sauerbruch.   

Abstract

BACKGROUND: Alcohol is a common cause of hepatic liver injury with steatosis and fibrosis. Cannabinoid receptors (CB) modulate steatosis, inflammation and fibrogenesis. To investigate the differences between CB(1) and CB(2) in the hepatic response to chronic alcohol intake, we examined CB knockout mice (CB(1)(-/-), CB(2)(-/-)).
METHODS: Eight- to 10-week-old CB(1)(-/-), CB(2)(-/-) and wild-type mice received 16% ethanol for 35 weeks. Animals receiving water served as controls. We analysed triglyceride and hydroxyproline contents in liver homogenates. mRNA levels of CBs, pro-inflammatory cytokines [tumour necrosis factor (TNF)-α, monocyte chemotactic protein (MCP)-1, interleukin (IL)-1β] and profibrotic factors [α-smooth muscle actin (α-SMA), procollagen-Ia, platelet-derived growth factor β receptor (PDGFβ-R)] were analysed by reverse transcription-polymerase chain reaction (RT-PCR). Histology (hemalaun and eosin, oil-red O, CD3, CD45R, CD45, F4/80, Sirius red) characterized hepatic steatosis, inflammation and fibrosis. Activation of lipogenic pathways, activation and proliferation of hepatic stellate cell (HSC) were assessed by western blot [fatty acid synthase (FAS), sterol regulatory element binding protein 1c (SREBP-1c), α-SMA, proliferating cell nuclear antigen (PCNA), cathepsin D].
RESULTS: Hepatic mRNA levels of the respective CBs were increased in wild-type animals and in CB(1)(-/-) mice after ethanol intake. Ethanol intake in CB(2)(-/-) mice induced much higher steatosis (SREBP-1c mediated) and inflammation (B-cell predominant infiltrates) compared with wild-type animals and CB(1)(-/-) mice. HSC activation and collagen production were increased in all groups after forced ethanol intake, being most pronounced in CB(2)(-/-) mice and least pronounced in CB(1)(-/-) mice. DISCUSSION: The fact that CB(2) receptor knockout mice exhibited the most pronounced liver damage after ethanol challenge indicates a protective role of CB(2) receptor expression in chronic ethanol intake. By contrast, in CB(1) knockouts, the effect of ethanol was attenuated, suggesting aggravation of fibrogenesis and SREBP-1c-mediated steatosis via CB(1) receptor expression after ethanol intake.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645218     DOI: 10.1111/j.1478-3231.2011.02496.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  40 in total

1.  [On the legalization debate of non-medical cannabis consumption : Position paper of the German Association for Psychiatry, Psychotherapy and Psychosomatics].

Authors:  U Havemann-Reinecke; E Hoch; U W Preuss; F Kiefer; A Batra; G Gerlinger; I Hauth
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

2.  Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Resat Cinar; Bernadette R Gochuico; Malliga R Iyer; Tony Jourdan; Tadafumi Yokoyama; Joshua K Park; Nathan J Coffey; Hadass Pri-Chen; Gergő Szanda; Ziyi Liu; Ken Mackie; William A Gahl; George Kunos
Journal:  JCI Insight       Date:  2017-04-20

3.  Metabolic Profiling of CB1 Neutral Antagonists.

Authors:  Herbert H Seltzman; Rangan Maitra; Katharine Bortoff; Jay Henson; Patricia H Reggio; Daniel Wesley; Joseph Tam
Journal:  Methods Enzymol       Date:  2017-07-10       Impact factor: 1.600

4.  Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis.

Authors:  Won-Mook Choi; Hee-Hoon Kim; Myung-Ho Kim; Resat Cinar; Hyon-Seung Yi; Hyuk Soo Eun; Seok-Hwan Kim; Young Jae Choi; Young-Sun Lee; So Yeon Kim; Wonhyo Seo; Jun-Hee Lee; Young-Ri Shim; Ye Eun Kim; Keungmo Yang; Tom Ryu; Jung Hwan Hwang; Chul-Ho Lee; Hueng-Sik Choi; Bin Gao; Won Kim; Sang Kyum Kim; George Kunos; Won-Il Jeong
Journal:  Cell Metab       Date:  2019-08-29       Impact factor: 27.287

5.  Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.

Authors:  Michaela Granzow; Robert Schierwagen; Sabine Klein; Benita Kowallick; Sebastian Huss; Markus Linhart; Irela G Reza Mazar; Jan Görtzen; Annabelle Vogt; Frank A Schildberg; Maria A Gonzalez-Carmona; Alexandra Wojtalla; Benjamin Krämer; Jacob Nattermann; Sören V Siegmund; Nikos Werner; Dieter O Fürst; Wim Laleman; Percy Knolle; Vijay H Shah; Tilman Sauerbruch; Jonel Trebicka
Journal:  Hepatology       Date:  2014-05-06       Impact factor: 17.425

6.  Cannabinoid receptor type I modulates alcohol-induced liver fibrosis.

Authors:  Eleonora Patsenker; Matthias Stoll; Gunda Millonig; Abbas Agaimy; Till Wissniowski; Vreni Schneider; Sebastian Mueller; Rudolf Brenneisen; Helmut K Seitz; Matthias Ocker; Felix Stickel
Journal:  Mol Med       Date:  2011-08-19       Impact factor: 6.354

7.  Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1.

Authors:  Irina Bronova; Brett Smith; Bulent Aydogan; Ralph R Weichselbaum; Kiran Vemuri; Katalin Erdelyi; Alex Makriyannis; Pal Pacher; Evgeny V Berdyshev
Journal:  Am J Respir Cell Mol Biol       Date:  2015-10       Impact factor: 6.914

8.  Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis.

Authors:  Resat Cinar; Malliga R Iyer; Ziyi Liu; Zongxian Cao; Tony Jourdan; Katalin Erdelyi; Grzegorz Godlewski; Gergő Szanda; Jie Liu; Joshua K Park; Bani Mukhopadhyay; Avi Z Rosenberg; Jeih-San Liow; Robin G Lorenz; Pal Pacher; Robert B Innis; George Kunos
Journal:  JCI Insight       Date:  2016-07-21

9.  Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase.

Authors:  Mi Wang; Justine M Abais; Nan Meng; Yang Zhang; Joseph K Ritter; Pin-Lan Li; Wang-Xian Tang
Journal:  Free Radic Biol Med       Date:  2014-03-19       Impact factor: 7.376

Review 10.  Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.